INFORMATION FOR
News
Inhibiting vascular mimicry is a promising approach for treating melanoma brain metastases, say Yale researchers.
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
There have been 121 faculty appointments and promotions across 11 sections in the Department of Internal Medicine since September of 2018.
Former YCCI scholars, Christopher Pittenger, Eda Cengiz, Lucia Jilaveanu, Forrest Crawford, Tore Eid, and Shangqin Guo reflect on being a scholar.
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients. The study is one of the first clinical trials aimed at treating the brain metastases with this type of cancer drug.
The American Cancer Society (ACS), the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University. These grants are among 11 new projects in effect across New England as of January 1, 2017 totaling more than $4.4 million dollars.